Evaluation of anti-invasion effect of cannabinoids on human hepatocarcinoma cells

Anti-tumoral action of cannabinoids on hepatocellular carcinoma: role of AMPK-dependent activation of autophagy

(2011) D Vara et al.   CELL DEATH AND DIFFERENTIATION

Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting

(2010) Chrisostomi Gialeli et al.   FEBS Journal

The Synthetic Cannabinoid WIN 55,212-2 Sensitizes Hepatocellular Carcinoma Cells to Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL)-Induced Apoptosis by Activating p8/CCAAT/Enhancer Binding Protein Homologous Protein (CHOP)/Death Receptor 5 (DR5) Axis

(2010) O. Pellerito et al.   MOLECULAR PHARMACOLOGY

Inhibition of human tumour prostate PC-3 cell growth by cannabinoids R(+)-Methanandamide and JWH-015: Involvement of CB2

(2009) N Olea-Herrero et al.   BRITISH JOURNAL OF CANCER

NF-κB inhibition in human hepatocellular carcinoma and its potential as adjunct to sorafenib based therapy

(2009) Jian-Min Wu et al.   CANCER LETTERS

Involvement of PI3K/PTEN/AKT/mTOR pathway in invasion and metastasis in hepatocellular carcinoma: Association with MMP-9

(2009) Jing-song Chen et al.   HEPATOLOGY RESEARCH

Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer

(2009) Z. Qamri et al.   MOLECULAR CANCER THERAPEUTICS

Apoptosis induced in HepG2 cells by the synthetic cannabinoid WIN: Involvement of the transcription factor PPARγ

(2008) Michela Giuliano et al.   BIOCHIMIE

Cannabinoids for Cancer Treatment: Progress and Promise

(2008) S. Sarfaraz et al.   CANCER RESEARCH

VIP inhibits human HepG2 cell proliferation in vitro

(2007) Afaf Absood et al.   REGULATORY PEPTIDES